Silvio Danese, MD, PhD

IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Italy

Poster(s):

• P3547 - Vedolizumab Long-Term Treatment Persistence and Safety – Results From a Multinational Extended Access Program Study
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT

• P3548 - Target Engagement and Pharmacodynamic Molecular Mechanism Evaluation in a Phase 1b Study of the Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat Containing X1 (NLRX1) Agonist NX-13 in Ulcerative Colitis
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT